BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34247018)

  • 1. Reduced frequency and functional potency of CD49d
    Borzouei S; Mohamadtaheri M; Zamani A; Behzad M
    Immunobiology; 2021 Jul; 226(4):152113. PubMed ID: 34247018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased regulatory function of CD4
    Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M
    Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased suppression of CD8
    Giri PS; Dwivedi M; Begum R
    Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD4+CD25+Foxp3+ Regulatory T Cells, Interleukin 10 and Transforming Growth Factor β in Newly Diagnosed Type 2 Diabetic Patients.
    Yuan N; Zhang HF; Wei Q; Wang P; Guo WY
    Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):96-101. PubMed ID: 28954308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of interleukin-32α on T helper cell-related cytokines, transcription factors, and proliferation in patients with type 2 diabetes mellitus.
    Borzouei S; Gholamian-Hamadan M; Behzad M
    Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):268-276. PubMed ID: 36263937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD49d Treg cells with high suppressive capacity are remarkably less efficient on activated CD45RA- than on naive CD45RA+ Teff cells.
    Kraczyk B; Remus R; Hardt C
    Cell Physiol Biochem; 2014; 34(2):346-55. PubMed ID: 25060807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-γ, IL-2 and IL-2R.
    Zhao J; Zhao J; Perlman S
    PLoS One; 2012; 7(9):e46241. PubMed ID: 23029447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α.
    Gradolatto A; Nazzal D; Truffault F; Bismuth J; Fadel E; Foti M; Berrih-Aknin S
    J Autoimmun; 2014 Aug; 52():53-63. PubMed ID: 24405842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms.
    Yin M; Zhang J; Wang Y; Wang S; Böckler D; Duan Z; Xin S
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1825-31. PubMed ID: 20448211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
    Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
    Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn's disease.
    Khalili A; Ebrahimpour S; Maleki I; Abediankenari S; Afrouzi MM
    Rom J Intern Med; 2018 Sep; 56(3):158-166. PubMed ID: 29453928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
    Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
    Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells.
    Kleinewietfeld M; Starke M; Di Mitri D; Borsellino G; Battistini L; Rötzschke O; Falk K
    Blood; 2009 Jan; 113(4):827-36. PubMed ID: 18941119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4(+)CD25(High) Treg cells in HIV/HTLV co-infected patients with neuropathy: high expression of Alpha4 integrin and lower expression of Foxp3 transcription factor.
    Matavele Chissumba R; Silva-Barbosa SD; Augusto Â; Maueia C; Mabunda N; Gudo ES; Bhatt N; Jani I; Savino W
    BMC Immunol; 2015 Sep; 16():52. PubMed ID: 26329520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4
    Wei Y; Yu K; Wei H; Su X; Zhu R; Shi H; Sun H; Luo Q; Xu W; Xiao J; Zhong Y; Zeng Q
    Immunology; 2017 Jul; 151(3):291-303. PubMed ID: 28207945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of Regulatory T Cells and of Proinflammatory and Immunosuppressive Cytokines in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    Qiao YC; Shen J; He L; Hong XZ; Tian F; Pan YH; Liang L; Zhang XX; Zhao HL
    J Diabetes Res; 2016; 2016():3694957. PubMed ID: 27777959
    [No Abstract]   [Full Text] [Related]  

  • 18. Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.
    Hamza E; Gerber V; Steinbach F; Marti E
    Immunology; 2011 Nov; 134(3):292-304. PubMed ID: 21977999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].
    Wang ZH; Zhu JY; Li T; Leng XS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):844-7. PubMed ID: 18756991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired CD4+ and T-helper 17 cell memory response to Streptococcus pneumoniae is associated with elevated glucose and percent glycated hemoglobin A1c in Mexican Americans with type 2 diabetes mellitus.
    Martinez PJ; Mathews C; Actor JK; Hwang SA; Brown EL; De Santiago HK; Fisher Hoch SP; McCormick JB; Mirza S
    Transl Res; 2014 Jan; 163(1):53-63. PubMed ID: 23927943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.